A Baby From Three
By Govind Vijaykumar,
The Asian Age
| 03. 08. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Within a year, the world could see the first of what’s being described as the three-parent baby. And it’s one of mankind’s riskiest endeavours
There’s currently tension within the world’s scientific community. Groups are hurling accusations at each other — ranging from manipulation of data, blatant disregard for human life and for having the sort of enthusiasm that kills off any lab-based endeavour. Whilst one group prepares to announce to the world a life-changing procedure, the other maintains that we have collectively jumped the gun.
All this over a baby… the first ever to be born as a result of modification, rather than just natural progression — a child born from three different humans.
What it’s all about
The idea is simple. A procedure will replace faulty, trouble-causing DNA in the mother’s egg with healthy DNA from a donor woman allowing the child to possess, for the first time in our evolutionary history, genetic inputs from two mothers and one father. Proponents of this technique believe an injection of healthy donor DNA will cancel out life-threatening genetic conditions...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...